980 related articles for article (PubMed ID: 21514718)
1. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
[TBL] [Abstract][Full Text] [Related]
2. Real indications for adrenalectomy in renal cell carcinoma.
Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
Kuczyk M; Wegener G; Jonas U
Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
6. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
[TBL] [Abstract][Full Text] [Related]
7. Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm.
Paul R; Mordhorst J; Busch R; Leyh H; Hartung R
J Urol; 2001 Jul; 166(1):59-62. PubMed ID: 11435823
[TBL] [Abstract][Full Text] [Related]
8. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous adrenalectomy during radical nephrectomy for renal cell carcinoma will not cure patients with adrenal metastasis.
von Knobloch R; Schrader AJ; Walthers EM; Hofmann R
Urology; 2009 Feb; 73(2):333-6. PubMed ID: 19038420
[TBL] [Abstract][Full Text] [Related]
10. Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival.
Yap SA; Alibhai SM; Abouassaly R; Timilshina N; Margel D; Finelli A
BJU Int; 2013 Mar; 111(3 Pt B):E54-8. PubMed ID: 23039377
[TBL] [Abstract][Full Text] [Related]
11. Reconsidering the necessity of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma.
Leibovitch I; Raviv G; Mor Y; Nativ O; Goldwasser B
Urology; 1995 Sep; 46(3):316-20. PubMed ID: 7660505
[TBL] [Abstract][Full Text] [Related]
12. Management of the adrenal gland during partial nephrectomy.
Lane BR; Tiong HY; Campbell SC; Fergany AF; Weight CJ; Larson BT; Novick AC; Flechner SM
J Urol; 2009 Jun; 181(6):2430-6; discussion 2436-7. PubMed ID: 19371896
[TBL] [Abstract][Full Text] [Related]
13. Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system.
Alamdari FI; Ljungberg B
Scand J Urol Nephrol; 2005; 39(4):277-82. PubMed ID: 16118103
[TBL] [Abstract][Full Text] [Related]
14. [Kidney cancer metastasis to the adrenal gland. Role of adrenalectomy].
Matveev VB; Baronin AA
Urologiia; 2002; (3):11-5. PubMed ID: 12180050
[TBL] [Abstract][Full Text] [Related]
15. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
16. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma.
Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Hirayama T; Okayasu I; Baba S
Urology; 2007 May; 69(5):839-42. PubMed ID: 17482918
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival after surgery for adrenal metastasis.
Muth A; Persson F; Jansson S; Johanson V; Ahlman H; Wängberg B
Eur J Surg Oncol; 2010 Jul; 36(7):699-704. PubMed ID: 20452170
[TBL] [Abstract][Full Text] [Related]
19. Investigation on the indication of ipsilateral adrenalectomy in radical nephrectomy: a meta-analysis.
Su JR; Zhu DJ; Liang W; Xie WL
Chin Med J (Engl); 2012 Nov; 125(21):3885-90. PubMed ID: 23106893
[TBL] [Abstract][Full Text] [Related]
20. Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy?
Yokoyama H; Tanaka M
BJU Int; 2005 Mar; 95(4):526-9. PubMed ID: 15705073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
